InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,537.02
(
0.51%
)
US TECH 100
19,641.60
(
0.83%
)
Dow Jones
39,308.00
(
-0.06%
)
Brent Oil
86.91
(
-0.48%
)
Bitcoin
54,427.30
(
-4.48%
)

Replies to post #64712 on NorthWest Biotherapeutics Inc (NWBO)

Replies to #64712 on NorthWest Biotherapeutics Inc (NWBO)

beartrap12

06/16/16 10:52 PM

#64735 RE: sentiment_stocks #64712

Senti, since the DCVaxL trial is only seeking approval for new GBM nor recurring, is there any way that they can be approved by FDA for recurring GBM based on data from the EAP trial? Ever since the second trial was started for rapid progressors I've wondered if it could be used to prove the effectiveness of DCVaxL on rGBM. I know it doesn't have a control group, but the data we've seen is remarkable. I can't imagine FDA ignoring it.
Great thoughts. Thank you for sharing.

beartrap12

06/16/16 10:52 PM

#64736 RE: sentiment_stocks #64712

Senti, since the DCVaxL trial is only seeking approval for new GBM nor recurring, is there any way that they can be approved by FDA for recurring GBM based on data from the EAP trial? Ever since the second trial was started for rapid progressors I've wondered if it could be used to prove the effectiveness of DCVaxL on rGBM. I know it doesn't have a control group, but the data we've seen is remarkable. I can't imagine FDA ignoring it.
Great thoughts. Thank you for sharing.